REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/30/2026
Back to search
Official data from USPTO
MEREO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
05/31/2026
Trademark type
Word
Nice classes
5, 42
Filing date
05/04/2016
Registration date
05/30/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/05/2024
Last transaction
05/31/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CROWLEY, SEAN MICHAEL
Law office
M70
Holders and representatives
Holders
Mereo BioPharma Group Plc
Mereo BioPharma Group Limited
Representatives
Anessa Owen Kramer Honigman LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and biopharmaceutical preparations and drugs for the treatment of rare and specialist diseases and conditions; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of orphan diseases; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of inflammatory diseases; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of respiratory disorders; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of chronic obstructive pulmonary disease (COPD); pharmaceutical and biopharmaceutical preparations and drugs for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD); pharmaceutical and biopharmaceutical preparations and drugsbronchodilators and anti-asthma preparations; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of osteogenesis imperfecta (OI) (brittle bone syndrome); pharmaceutical and biopharmaceutical preparations and drugs to improve bone density and treat bone weakness; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of obesity; pharmaceutical and biopharmaceutical preparations and drugs for normalising testosterone levels; pharmaceutical and biopharmaceutical preparations and drugsaromatase inhibitors (AIs); pharmaceutical and biopharmaceutical preparations and drugs for treating hypogonadotrophic hypogonadism (HH); antibiotics
Class 42
Scientific research and design relating thereto; industrial analysis and research services in the field of medicine and disease; medical and pharmaceutical research services; scientific research for medical purposes; researchinspectiontestingdevelopment and evaluation of the pharmaceutical products of others in the field of medicine and disease; researchinspectiontestingdevelopment and evaluation of pharmaceutical and veterinary preparationsproducts and drugs; conducting clinical trials for others; informationadvisory and consultancy services relating to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
43 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/16/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/19/2026
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
08/11/2025
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
12/06/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/29/2024
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/22/2024
INPC
INVALIDATION PROCESSED
10/22/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/06/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/05/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
02/05/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/29/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
05/30/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/30/2022
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/28/2019
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
01/17/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/28/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/13/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/08/2017
FIMP
FINAL DISPOSITION PROCESSED
09/08/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/30/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2017
PUBO
PUBLISHED FOR OPPOSITION
03/14/2017
GPNX
NOTIFICATION PROCESSED BY IB
03/10/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/22/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/22/2017
NPUB
NOTICE OF PUBLICATION
02/22/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/20/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/19/2017
ALIE
ASSIGNED TO LIE
01/18/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2016
RFNT
REFUSAL PROCESSED BY IB
09/16/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/30/2016
RFRR
REFUSAL PROCESSED BY MPU
08/30/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/30/2016
CNRT
NON-FINAL ACTION WRITTEN
08/29/2016
DOCK
ASSIGNED TO EXAMINER
08/20/2016
MAFR
APPLICATION FILING RECEIPT MAILED
07/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/21/2016
Continuous trademark protection
Get notified about every new filing that threatens MEREO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.